Palo-Alto-Investors-Lp
AI_NATIVE detailed information: This accession holds the following tickers:[ "ALKS", "INSM", "TIL", "ACAD", "HUM", "PTCT", "STAA", "ALNY", "FOLD", "NVCR", "ANAB", "BCYC", "SLRN", "MIRM", "TVTX", "TSHA", "NUVB", "STOK", "SNDX", "ABEO", "PRTA", "ALDX", "NBIX", "PYXS", "RLMD", "IOVA", "AKTX", "ACRS", "UTHR", "AGIO", "DYN", "GOSS", "EW", "SRPT", "ALGN", null, "EHTH", "GBIO", "URGN", "VERV", "VYNE", "BIIB", "BNTX", "BMRN" ]
Filing Details
13F-HR • 2025-03-31
Filing Details
13F-HR • 2025-03-31- Report Date
- 2025-03-31
- Filing Date
- 2025-05-15
- Total Holdings
- 44
- Total Value
- 525145308
- Accession Number
- 0001306923-25-000014
- Form Type
- 13F-HR
- Manager Name
- Palo-Alto-Investors-Lp
Data Enrichment
98% identified43 identified1 unidentified
Holdings
44 positions • $525.1M total value
Manager:
Search and click to pin securities to the top
Page 1 of 3
Shares:991.2K
Value:$70.1M
% of Portfolio:13.3% ($70.1M/$525.1M)
Shares:83.5K
Value:$22.5M
% of Portfolio:4.3% ($22.5M/$525.1M)
Shares:1.7M
Value:$20.5M
% of Portfolio:3.9% ($20.5M/$525.1M)
Shares:210.3K
Value:$13.4M
% of Portfolio:2.6% ($13.4M/$525.1M)
Shares:3.2M
Value:$10.7M
% of Portfolio:2.0% ($10.7M/$525.1M)
Shares:276.6K
Value:$8.1M
% of Portfolio:1.5% ($8.1M/$525.1M)
Instrument | Shares | Other Manager | Value | % of Portfolio | ||
---|---|---|---|---|---|---|
INSMED Inc(INSMcusip457669307) | 987.2K | All Managers (Combined) | $75.3M | 14.3% ($75.3M/$525.1M) | ||
991.2K | All Managers (Combined) | $70.1M | 13.3% ($70.1M/$525.1M) | |||
7.3M | All Managers (Combined) | $59.9M | 11.4% ($59.9M/$525.1M) | |||
2.7M | All Managers (Combined) | $44.2M | 8.4% ($44.2M/$525.1M) | |||
105.2K | All Managers (Combined) | $32.4M | 6.2% ($32.4M/$525.1M) | |||
BIOGEN INC.(BIIBcusip09062X103) | 204.9K | All Managers (Combined) | $28.0M | 5.3% ($28.0M/$525.1M) | ||
83.5K | All Managers (Combined) | $22.5M | 4.3% ($22.5M/$525.1M) | |||
404.2K | YoY NEW(+404.2K) | All Managers (Combined) | $20.6M | 3.9% ($20.6M/$525.1M) | YoY NEW(+$20.6M) | |
1.7M | All Managers (Combined) | $20.5M | 3.9% ($20.5M/$525.1M) | |||
ANAPTYSBIO, INC(ANABcusip032724106) | 1.0M | All Managers (Combined) | $19.0M | 3.6% ($19.0M/$525.1M) | ||
NovoCure Ltd(NVCRcusipG6674U108) | 1.0M | All Managers (Combined) | $17.9M | 3.4% ($17.9M/$525.1M) | ||
210.3K | QoQ 0.00% (-0) | All Managers (Combined) | $13.4M | 2.6% ($13.4M/$525.1M) | ||
eHealth, Inc.(EHTHcusip28238P109) | 1.7M | All Managers (Combined) | $11.3M | 2.1% ($11.3M/$525.1M) | ||
3.2M | All Managers (Combined) | $10.7M | 2.0% ($10.7M/$525.1M) | |||
525.0K | All Managers (Combined) | $9.3M | 1.8% ($9.3M/$525.1M) | |||
276.6K | QoQ NEW(+276.6K) YoY NEW(+276.6K) | All Managers (Combined) | $8.1M | 1.5% ($8.1M/$525.1M) | QoQ NEW(+$8.1M) YoY NEW(+$8.1M) | |
Alkermes plc.(ALKScusipG01767105) | 221.5K | All Managers (Combined) | $7.3M | 1.4% ($7.3M/$525.1M) | ||
6.3M | All Managers (Combined) | $6.9M | 1.3% ($6.9M/$525.1M) | |||
37.8K | QoQ 0.00% (-0) | All Managers (Combined) | $6.0M | 1.1% ($6.0M/$525.1M) | ||
444.4K | All Managers (Combined) | $5.5M | 1.0% ($5.5M/$525.1M) |